Credential Qtrade Securities Inc. Biogen Inc. Transaction History

Credential Qtrade Securities Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jul 21, 2025	SELL	$252.44 - $306.72 $4,291 - $5,214	-17 Closed	0 $0
Q3 2022 Jul 21, 2025	BUY	$194.69 - $268.46 $3,309 - $4,563	17 New	17 $4.54 Million
Q1 2022 Jul 21, 2025	SELL	$193.77 - $244.14 $581 - $732	-3 Closed	0 $0
Q4 2021 Jul 21, 2025	BUY	$223.92 - $287.77 $671 - $863	3 New	3 $719,000
Q2 2019 Jul 21, 2025	SELL	$219.29 - $241.72 $155,695 - $171,621	-710 Closed	0 $0
Q1 2019 Jul 21, 2025	BUY	$216.71 - $338.96 $18,637 - $29,150	86 Added 13.78%	710 $168 Million
Q4 2018 Jul 21, 2025	SELL	$278.5 - $352.75 $66,004 - $83,601	-237 Reduced 27.53%	624 $188 Million
Q3 2018 Jul 21, 2025	BUY	$293.51 - $383.83 $252,712 - $330,477	861 New	861 $304 Million

1,023

126M

2.32M

4.26M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.